Correction: .
出版信息
J Immunother Cancer. 2021 Dec;9(12). doi: 10.1136/jitc-2021-002597corr1.
Abstract
摘要
相似文献
1
Correction: .更正：.
J Immunother Cancer. 2021 Dec;9(12). doi: 10.1136/jitc-2021-002597corr1.
2
Correction: Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of gynecologic cancer.更正：癌症免疫治疗学会（SITC）关于妇科癌症免疫治疗的临床实践指南。
J Immunother Cancer. 2023 Jun;11(6):1. doi: 10.1136/jitc-2022-006624corr1.
3
Correction.更正。
J Immunother Cancer. 2021 Jan;9(1). doi: 10.1136/jitc-2020-001235corr1.
4
The Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of acute leukemia.癌症免疫治疗学会（SITC）关于免疫疗法治疗急性白血病的临床实践指南。
J Immunother Cancer. 2020 Oct;8(2). doi: 10.1136/jitc-2020-000810.
5
Correction: Defining current gaps in quality measures for cancer immunotherapy: consensus report from the society for immunotherapy of cancer (SITC) 2019 Quality Summit.更正：界定癌症免疫治疗质量指标的当前差距：癌症免疫治疗协会（SITC）2019年质量峰会共识报告
J Immunother Cancer. 2020 Apr;8(1). doi: 10.1136/jitc-2019-000112corr1.
6
Highlights of the 31st annual meeting of the Society for Immunotherapy of Cancer (SITC), 2016.第 31 届癌症免疫治疗学会（SITC）年会要点，2016 年。
J Immunother Cancer. 2017 Jul 18;5(1):55. doi: 10.1186/s40425-017-0262-1.
7
Correction to: 33rd Annual Meeting & Pre-Conference Programs of the Society for Immunotherapy of Cancer (SITC 2018).更正至：癌症免疫治疗学会第33届年会及会前项目（SITC 2018）。
J Immunother Cancer. 2019 Feb 13;7(1):46. doi: 10.1186/s40425-019-0519-y.
8
Immuno-oncology biomarkers 2010 and beyond: perspectives from the iSBTc/SITC biomarker task force.免疫肿瘤生物标志物 2010 年及以后：iSBTc/SITC 生物标志物工作组的观点。
J Transl Med. 2010 Dec 7;8:130. doi: 10.1186/1479-5876-8-130.
9
Preamble to the 2015 SITC immunotherapy biomarkers taskforce.前言 2015 年 SITC 免疫治疗生物标志物工作组
J Immunother Cancer. 2015 Mar 24;3:8. doi: 10.1186/s40425-015-0052-6. eCollection 2015.
10
Correction: Society for Immunotherapy of Cancer (SITC) checkpoint inhibitor resistance definitions: efforts to harmonize terminology and accelerate immuno-oncology drug development.更正：癌症免疫治疗学会（SITC）检查点抑制剂耐药性定义：统一术语并加速免疫肿瘤学药物开发的努力
J Immunother Cancer. 2023 Sep;11(9). doi: 10.1136/jitc-2023-007309corr1.
引用本文的文献
1
Long-Lasting Complete Remission in a Patient With Metastatic Metaplastic Breast Cancer Treated With Immune Checkpoint Inhibitor and Chemotherapy: A Case Report and a Review of the Literature.免疫检查点抑制剂联合化疗治疗转移性化生性乳腺癌患者的长期完全缓解：病例报告及文献综述
Cureus. 2024 Feb 1;16(2):e53419. doi: 10.7759/cureus.53419. eCollection 2024 Feb.
2
Comprehensive characterization of immune landscape of Indian and Western triple negative breast cancers.印度和西方三阴性乳腺癌免疫图谱的综合表征。
Transl Oncol. 2022 Nov;25:101511. doi: 10.1016/j.tranon.2022.101511. Epub 2022 Aug 11.
Zotero 插件